Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

3yrs ago Private Equity privateequitywire Views: 369

Blackstone-backed HealthEdge acquires The Burgess Group

Submitted 14/08/2020 - 9:19am

HealthEdge, the provider of HealthRules Payor,van integrated financial, administrative and clinical platform for health insurers, has completed the acquisition of The Burgess Group (Burgess), a payment integrity software company focused on improving healthcare payment operations through technology. 

Health plan customers will now benefit from claims cost savings via the Burgess Source platform’s ability to identify and reduce wasteful spending in the US healthcare system.

“We are really excited about the future of HealthEdge,” says Steve Krupa, CEO of HealthEdge. “Our company’s growth and maturation, coupled with strategic and capital support from our investors, have enabled us to take a significant step toward creating a fully automated cloud-based transactional system for health plans by partnering with Greg Burgess and his team.”

“The Burgess Group team is hitting the ground running with HealthEdge,” says Greg Burgess, Founder and President. “Driving solutions in the payment integrity arena has been our heart and soul for nearly 25 years. Together with HealthEdge, we will maximise efficiencies through our collective experience and ultimately create win-win scenarios for health plans, patients and participating providers.”

The Burgess acquisition follows the purchase of a majority stake in HealthEdge by funds managed by Blackstone in April 2020.

Ram Jagannath, Global Head of Healthcare for Blackstone Growth and Chairman of HealthEdge, says: “We are excited to back HealthEdge as a leading next-generation payor software company and we see HealthEdge as a platform for further strategic acquisitions. HealthEdge’s acquisition of Burgess provides a critical adjacency in payment integrity software to further strengthen our value proposition to health plan customers.”

TripleTree, LLC served as financial advisor and Debevoise & Plimpton LLP was legal advisor to HealthEdge and Blackstone. Seabrook Partners, LLC served as financial advisor and Vedder Price was legal advisor to Burgess. Terms of the transaction have not been disclosed.

Tags Deals & Transactions Acquisitions

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.